I'd buy this ASX share this week

If I could only buy one ASX share this week it would be infant formula stock Bubs Australia Ltd (ASX:BUB). It has lots of growth potential.

| More on:
piggy bank wearing crown representing asx share dividend king

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If I had to pick which ASX share I'd buy this week, other than last week's pick, it would be Bubs Australia Ltd (ASX: BUB).

A quick overview of Bubs

Bubs is best known as an infant formula business. The company was set up in 2006 by current-CEO Kristy Carr.

The ASX share's main range of products is a goat milk derived infant formula. Three years ago Bubs acquired NuLac Foods, Australia's largest producer of goat milk products, including CapriLac, a leader in goat milk, powder and yoghurt, and Coach House Dairy, a premium range of Jersey milk products. That acquisition guaranteed exclusive supply of locally sourced fresh goat milk from Australia's largest herd of milking goats.

Bubs also owns its a Chinese-approved manufacturing facility called Deloraine.

I think Bubs is a great buy for a number of reasons:

International growth

Entering the global market can turn a consumer business from being a decent opportunity to one with much larger potential. Look how much further A2 Milk Company Ltd (ASX: A2M) has grown because it is servicing the Asian and USA markets.

Bubs is doing a really good job of getting its foot into the door of international markets. We can see the growth in the ASX share's June 2020 update a few weeks ago.

In the quarter ending 30 June 2020 we saw Bubs' China direct sales increase by 37% – this now represents around a fifth of total sales. Its 'other export' sales were up 71% in the fourth quarter of FY20, largely helped by the launch into Vietnam. Other international sales accounted for 9% of total sales in FY20.

Asia is a much larger total addressable market for Bubs compared to Australia. This region alone could be enough for the company to be a long-term market outperformer.

I like the ASX share's recent moves of launching grass-fed organic cow infant formula as well as a range of vitamin and mineral supplements. Both of these segments could become material for Bubs in the next few years as their distribution grows across various stores.

Defensive, essential product

I think this COVID-19 period has shown us how important Bubs' products are to families. Nutrition is essential, it's not a discretionary item. I think Bubs' existing revenue base is more defensive than some investors may give it credit for.

We saw in the FY20 third quarter how much demand there was for Bubs' products when households were stocking up. The ASX share's revenue grew by 67% compared to the prior corresponding period and it went up 36% on the previous quarter.

Rising profit margins

An ASX share can generate strong returns when there is a combination of strong revenue growth and rising profit margins.

In FY20 the total revenue rose by 32% to $62 million and the 'normalised' gross profit margin improved by 3 basis points, according to Bubs.

What's most exciting is that infant formula, which has a gross profit margin of around 40%, is becoming a bigger part of Bubs' total sales. In FY19 it made up 43% of total revenue, in FY20 it was 55% of total revenue. In FY20 infant formula revenue increased by 69%.

Margins could rise further as Bubs grows into Singapore, Hong Kong and Malaysia.

Near-term profitability

Reaching profitability is one of the most important things for a business to convince investors that it's on the right path.

In FY21, excluding any residual COVID-19 adverse impacts, The ASX share expects to achieve profitability at the normalised earnings before interest, tax, depreciation and amortisation (EBITDA) level. That would be a very promising step. 

Bubs thinks the group margin will be further enhanced by optimised product mix, the highest and best use of the milk pool allocation and enhanced value chain.

Foolish takeaway

Bubs could see growth in every segment and every geographic region in FY21. I think there's a lot of promise for Bubs over the next 12 months and particularly the next five to ten years. I think Bubs is a very exciting business which is worth owning for the long-term, I'd be happy to buy it this week.

Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of BUBS AUST FPO. The Motley Fool Australia owns shares of A2 Milk. The Motley Fool Australia has recommended BUBS AUST FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Suncorp share price Businessman cheering and smiling on smartphone
Growth Shares

3 ASX 200 shares for smart investors to buy

Analysts think these shares could be smart buys this month. Let's find out why.

Read more »

Smiling couple looking at a phone at a bargain opportunity.
Growth Shares

Looking for ASX growth shares? I rate these 2 as buys in May

These ASX investments have an exciting future. Here’s why.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Growth Shares

The best ASX growth stocks for smart investors to buy with $5,000

Analysts are bullish on these shares. Let's find out why.

Read more »

Happy young couple saving money in piggy bank.
Growth Shares

Where to invest $2,500 into ASX 200 shares today

Analysts think these shares could be top buys for investors with money to invest.

Read more »

Two people having a meeting using a laptop and tablet to discuss Seven West Media's balance sheet
Growth Shares

3 excellent ASX shares to buy for your SMSF

Analysts think these shares could be top picks for SMSF investors. Let's find out why.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Growth Shares

2 ASX growth shares to supercharge your portfolio

Analysts think these shares could be in the buy zone for growth investors right now.

Read more »

A group of people gathered around a laptop computer with various expressions of interest, concern and surprise on their faces. All are wearing glasses.
Growth Shares

Turn $300 into significant wealth: 3 explosive ASX opportunities for Aussie investors

Analysts think these shares could be great picks for growth focused investors.

Read more »

A man looking at his laptop and thinking.
Growth Shares

What I'd buy with $2,000 on the ASX right now

Here are three options for investors to look at this month.

Read more »